.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Medtronic
Healthtrust
McKesson
Julphar
Teva
US Department of Justice
Colorcon
Moodys
Novartis

Generated: December 12, 2017

DrugPatentWatch Database Preview

Janssen Therap Company Profile

« Back to Dashboard

What is the competitive landscape for JANSSEN THERAP, and what generic alternatives to JANSSEN THERAP drugs are available?

JANSSEN THERAP has one approved drug.

There are two US patents protecting JANSSEN THERAP drugs.

There are eighty-five patent family members on JANSSEN THERAP drugs in thirty-nine countries and twelve supplementary protection certificates in nine countries.

Summary for Janssen Therap

International Patents:85
US Patents:2
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Janssen TherapSIRTURObedaquiline fumarateTABLET;ORAL204384-001Dec 28, 2012RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Janssen TherapSIRTURObedaquiline fumarateTABLET;ORAL204384-001Dec 28, 2012RXYesYes► Subscribe► Subscribe► SubscribeYY► Subscribe
Janssen TherapSIRTURObedaquiline fumarateTABLET;ORAL204384-001Dec 28, 2012RXYesYes► Subscribe► Subscribe► SubscribeYY► Subscribe
Janssen TherapSIRTURObedaquiline fumarateTABLET;ORAL204384-001Dec 28, 2012RXYesYes► Subscribe► Subscribe► SubscribeYY► Subscribe
Janssen TherapSIRTURObedaquiline fumarateTABLET;ORAL204384-001Dec 28, 2012RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Janssen Therap Drugs

Country Document Number Estimated Expiration
Argentina040673► Subscribe
Argentina064149► Subscribe
Netherlands300684► Subscribe
Israel199077► Subscribe
Portugal1527050► Subscribe
Eurasian Patent Organization008937► Subscribe
New Zealand538391► Subscribe
Spain2387923► Subscribe
China1671667► Subscribe
Spain2395237► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Janssen Therap Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
8 5021-2014Slovakia► SubscribePRODUCT NAME: BEDACHILIN FUMARAT; REGISTRATION NO/DATE: EU/1/13/901 20140305
2014032Lithuania► SubscribePRODUCT NAME: BEDAQUILINUM; REGISTRATION NO/DATE: EU/1/13/901 20140305
C0060France► SubscribePRODUCT NAME: BEDAQUILINE OU UN DE SES SELS D'ADDITION D'ACIDE OU DE BASE PHARMACEUTIQUEMENT ACCEPTABLE, Y COMPRIS LE FUMARATE DE BEDAQUILINE; REGISTRATION NO/DATE: EU/1/13/901 20140307
2014 00044Denmark► SubscribePRODUCT NAME: BEDAKILIN ELLER ET FARMACEUTISK ACCEPTABELT SYRE-ELLER BASEADDITIONSSALT DERAF, HERUNDER BEDAKILINFUMARAT; REG. NO/DATE: EU/1/13/901 20140305
0684Netherlands► SubscribePRODUCT NAME: BEDAQUILINE, OF EEN FARMACEUTISCH AANVAARDBAAR ZUUR- OF BASE-ADDITIEZOUT DAARVAN, WAARONDER BEDAQUILINEFUMARAAT; REGISTRATION NO/DATE: EU/1/13/901 20140307
00684Netherlands► SubscribePRODUCT NAME: BEDAQUILINE, OF EEN FARMACEUTISCH AANVAARDBAAR ZUUR- OF BASE-ADDITIEZOUT DAARVAN, WAARONDER BEDAQUILINEFUMARAAT; REGISTRATION NO/DATE: EU/1/13/901 20140307
0140026 00112Estonia► SubscribePRODUCT NAME: BEDAKVILIIN;REG NO/DATE: K(2014)1616 (LOPLIK) 07.03.2014
520Luxembourg► SubscribePRODUCT NAME: BEDAQUILINE, OU SON SEL D ADDITION D ACIDE OU DE BASE PHARMACEUTIQUEMENT ACCEPTABLE, Y COMPRIS LE FUMARATE DE BEDAQUILINE. FIRST REGISTRATION: 20140307
2014 00044Denmark► SubscribePRODUCT NAME: BEDAKILIN ELLER ET FARMACEUTISK ACCEPTABELT SYRE- ELLER BASEADDITIONSSALT DERAF, HERUNDER BEDAKILINFUMARAT; REG. NO/DATE: EU/1/13/901 20140305
14/045Ireland► SubscribePRODUCT NAME: BEDAQUILINE, OR A PHARMACEUTICALLY ACCEPTABLE ACID OR BASE ADDITION SALT THEREOF, INCLUDING BEDAQUILINE FUMARATE; REGISTRATION NO/DATE: EU/1/13/901 20140305
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
UBS
Merck
Chubb
Colorcon
Teva
US Department of Justice
Medtronic
Federal Trade Commission
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot